{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:25:54Z","timestamp":1781702754272,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"General Practice Education and Training","award":["026\/12"],"award-info":[{"award-number":["026\/12"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.vaccine.2014.04.046","type":"journal-article","created":{"date-parts":[[2014,6,9]],"date-time":"2014-06-09T13:08:17Z","timestamp":1402319297000},"page":"4214-4219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The missing link: Family physician perspectives on barriers and enablers to prescribing a new Meningococcal B vaccine and other recommended, non-government funded vaccines"],"prefix":"10.1016","volume":"32","author":[{"given":"Kathryn A.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Stocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen S.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3(Sep)","key":"10.1016\/j.vaccine.2014.04.046_bib0005","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1071\/SH09135","article-title":"National survey of general practitioners\u2019 experience of delivering the National Human Papillomavirus Vaccination Program","volume":"7","author":"Brotherton","year":"2010","journal-title":"Sex Health"},{"key":"10.1016\/j.vaccine.2014.04.046_bib0010","series-title":"The Australian immunisation handbook","author":"National Health and Medical Research Council","year":"2013"},{"key":"10.1016\/j.vaccine.2014.04.046_bib0015","series-title":"JCVI interim position statement on the use of Bexsero meningococcal B vaccine in the UK, July 2013 [last accessed 19 Nov 2013]","author":"Department of Health","year":"2013"},{"key":"10.1016\/j.vaccine.2014.04.046_bib0020","series-title":"PBAC meeting outcomes \u2013 first time decisions not to recommend, November 2013 [last accessed 12 Mar 2014]","author":"Pharmaceutical Benefits Advisory Committee","year":"2014"},{"issue":"1","key":"10.1016\/j.vaccine.2014.04.046_bib0025","first-page":"61","article-title":"Australia's notifiable disease status, 2010: annual report of the National Notifiable Diseases Surveillance System","volume":"36","author":"NNDSS Annual Report Writing Group","year":"2012","journal-title":"Commun Dis Intell"},{"issue":"3(Sep)","key":"10.1016\/j.vaccine.2014.04.046_bib0030","first-page":"E251","article-title":"Annual report of the Australian Meningococcal Surveillance Programme, 2011","volume":"36","author":"Lahra","year":"2012","journal-title":"Commun Dis Intell Q Rep"},{"issue":"18(Apr)","key":"10.1016\/j.vaccine.2014.04.046_bib0035","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.vaccine.2011.02.058","article-title":"The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease","volume":"29","author":"Harrison","year":"2011","journal-title":"Vaccine"},{"issue":"9(Sep)","key":"10.1016\/j.vaccine.2014.04.046_bib0040","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S1474-4422(12)70180-1","article-title":"Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study","volume":"11","author":"Viner","year":"2012","journal-title":"Lancet Neurol"},{"issue":"6(Feb)","key":"10.1016\/j.vaccine.2014.04.046_bib0045","first-page":"573","article-title":"Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial","volume":"307","author":"Gossger","year":"2012","journal-title":"JAMA"},{"issue":"8(Aug)","key":"10.1016\/j.vaccine.2014.04.046_bib0050","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(12)70087-7","article-title":"Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial","volume":"12","author":"Richmond","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2014.04.046_bib0055","series-title":"Clinical advice for providers regarding the use of Bexsero\u00ae","author":"Immunise Australia Program Website","year":"2014"},{"issue":"7(Apr)","key":"10.1016\/j.vaccine.2014.04.046_bib0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.5694\/mja12.11849","article-title":"Uptake of influenza vaccine by pregnant women: a cross-sectional survey","volume":"198","author":"Wiley","year":"2013","journal-title":"Med J Aust"},{"issue":"Jan(5)","key":"10.1016\/j.vaccine.2014.04.046_bib0065","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.vaccine.2009.12.063","article-title":"Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation","volume":"29","author":"Rosenthal","year":"2011","journal-title":"Vaccine"},{"issue":"9(Jan)","key":"10.1016\/j.vaccine.2014.04.046_bib0070","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.vaccine.2013.11.042","article-title":"Parental and community acceptance of the benefits and risks associated with meningococcal B vaccines","volume":"3","author":"Marshall","year":"2014","journal-title":"Vaccine"},{"issue":"6(Dec)","key":"10.1016\/j.vaccine.2014.04.046_bib0075","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/ajo.12002","article-title":"HPV vaccination of adult women: an audit of Australian general practitioners","volume":"52","author":"Mazza","year":"2012","journal-title":"Aust N Z J Obstet Gynaec"},{"issue":"5(Nov)","key":"10.1016\/j.vaccine.2014.04.046_bib0080","doi-asserted-by":"crossref","first-page":"e809","DOI":"10.1542\/peds.2008-3832","article-title":"Adoption of rotavirus vaccination by pediatricians and family medicine physicians in the United States","volume":"124","author":"Kempe","year":"2009","journal-title":"Pediatrics"},{"issue":"5(May)","key":"10.1016\/j.vaccine.2014.04.046_bib0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1440-1754.2009.01494.x","article-title":"Varicella immunisation practice: Implications for provision of a recommended, non-funded vaccine","volume":"45","author":"Marshall","year":"2009","journal-title":"J Paediatr Child Health"},{"issue":"5","key":"10.1016\/j.vaccine.2014.04.046_bib0090","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1046\/j.1440-1754.2003.00176.x","article-title":"Barriers to immunization: attitudes of general practitioners to varicella, the disease and its vaccine","volume":"39","author":"Milledge","year":"2003","journal-title":"J Paediatr Child Health"},{"issue":"5(May)","key":"10.1016\/j.vaccine.2014.04.046_bib0095","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.amepre.2010.12.025","article-title":"Prevalence of parental concerns about childhood vaccines: the experience of primary care physicians","volume":"40","author":"Kempe","year":"2011","journal-title":"Am J Prev Med"},{"issue":"10(Oct)","key":"10.1016\/j.vaccine.2014.04.046_bib0100","first-page":"1424","article-title":"Effects of various methodologic strategies: survey response rates among Canadian physicians and physicians-in-training","volume":"54","author":"Grava-Gubins","year":"2008","journal-title":"Can Fam Physician"},{"issue":"6(Jun)","key":"10.1016\/j.vaccine.2014.04.046_bib0105","first-page":"427","article-title":"Response rates in FP surveys \u2013 trialling two recruitment strategies","volume":"40","author":"Bonevski","year":"2011","journal-title":"Aust Fam Physician"},{"issue":"Sep","key":"10.1016\/j.vaccine.2014.04.046_bib0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1472-6963-9-160","article-title":"Response rates in postal surveys of healthcare professionals between 1996 and 2005: an observational study","volume":"9","author":"Cook","year":"2009","journal-title":"BMC Health Serv Res"},{"issue":"2(Apr)","key":"10.1016\/j.vaccine.2014.04.046_bib0115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1753-6405.2011.00687.x","article-title":"A comparison of general practitioner response rates to electronic and postal surveys in the setting of the National STI Prevention Program","volume":"35","author":"Crouch","year":"2011","journal-title":"Aust N Z J Public Health"},{"issue":"7059(Sep)","key":"10.1016\/j.vaccine.2014.04.046_bib0120","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/bmj.313.7059.732","article-title":"General practice postal surveys: a questionnaire too far?","volume":"313","author":"McAvoy","year":"1996","journal-title":"BMJ"},{"issue":"2(Apr)","key":"10.1016\/j.vaccine.2014.04.046_bib0125","first-page":"MR000008","article-title":"Methods to increase response rates to postal questionnaires","volume":"18","author":"Edwards","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2014.04.046_bib0130","article-title":"General practice activity in Australia 2008-2009","author":"Britt","year":"2009"},{"key":"10.1016\/j.vaccine.2014.04.046_bib0135","author":"Australian Institute of Health and Welfare","year":"2013"},{"key":"10.1016\/j.vaccine.2014.04.046_bib0140","series-title":"Healthy communities: immunisation rates for children in 2011-12. Released 11 April 2013","author":"National Health Performance Authority","year":"2013"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14005842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14005842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T14:24:36Z","timestamp":1538576676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14005842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":28,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0264410X14005842"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.046","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The missing link: Family physician perspectives on barriers and enablers to prescribing a new Meningococcal B vaccine and other recommended, non-government funded vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}